Abstracts Archive - Page 133 of 1683 - ATC Abstracts

2022 American Transplant Congress
HLA Alleles Add to Risk Stratification for CMV Infection in Renal Transplant Recipients
R. Patil¹, R. Prashar², M. Ramesh², A. Patel²
¹Wayne State University School of Medicine, Detroit, MI, ²Henry Ford Transplant Institute, Detroit, MI
*Purpose: Cytomegalovirus (CMV) is the most common viral infection that occurs after solid organ transplantation. The incidence of CMV infection or disease (I/d) varies based…
2022 American Transplant Congress
Ethnic Variation in Adult and Pediatric Liver Transplantation
N. Kemmer¹, M. Malespin¹, S. Agrawal¹, R. Syed¹, K. Alkhalloufi¹, B. Alkurdi¹, C. Albers¹, J. Buggs²
¹Tampa General Hospital, Tampa, FL, ²Transplant Surgery, Tampa General Hospital, Tampa, FL
*Purpose: Despite several policy reforms over the years, disparities in the access to solid organ transplantation continues to exist remains a significant barrier to liver…
2022 American Transplant Congress
Donor Kidney-Resident Passenger Macrophages Promote CCL8-CCR8 Mediated Early Allograft Inflammation
A. Dangi¹, I. Husain², N. Natesh³, X. Shen³, J. Kwun⁴, X. Luo⁵
¹Medicine, Duke University Medical Center, Durham, NC, ²Duke University Medical Center, Durham, NC, ³Biomedical Engineering, Duke University, Durham, NC, ⁴Duke Transplant Center, Durham, NC, ⁵Duke University School of Medicine, Durham, NC
*Purpose: Early intragraft infiltration of monocytes and macrophages has been associated with acute and chronic allograft rejections. Nevertheless, underlying mechanism remained poorly understood. In the…
2022 American Transplant Congress
Electrospun Poly-ε-Caprolactone Scaffolds Incorporating Decellularized Extracellular Matrix for Suturable Tissue Engineered Small Vascular Graft
A. Han¹, S. Min¹, E. Cho¹, H. Woo¹, A. Cho¹, J. Ha¹, Y. Ju², S. Min¹
¹Department of Surgery, Seoul National University College of Medicine, Seoul, Korea, Republic of, ²Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC
*Purpose: While small-sized grafts (1-5mm in diameter) are essential vascular conduits needed to replace diseased end arteries supplying vital organs or tissues, the use of…
2022 American Transplant Congress
Clinical Relevance of Class II HLA Mismatches in Living Donor Kidney Transplantation
J. Lan¹, M. Kadatz¹, D. Chang¹, R. Liwski², E. Wagner², P. Campbell², J. Gill¹, J. Gill¹
¹University of British Columbia, Vancouver, BC, Canada, ²On behalf of Canadian HLA Advisory Committee, Ottawa, ON, Canada
*Purpose: The benefit of class II HLA matching is primarily shown in deceased donor kidney transplantation. The objective of this study was to determine the…
2022 American Transplant Congress
Ventricular Modeling Following Bariatric Surgery Decreases Need for Heart Transplantation
R. Choudhury¹, A. Rouhi², G. Hoeltzel³, Y. Bababekov¹, A. Suarez-Pierre⁴, A. Yule¹, N. Vigneshwar⁴, N. Williams⁵, K. Dumon², T. Nydam¹
¹Transplantation Surgery, University of Colorado Hospital, Aurora, CO, ²General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, ³General Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, ⁴Cardiothoracic Surgery, University of Colorado Hospital, Aurora, CO, ⁵General Surgery, Hospital of the University of Pennsylvania, Aurora, CO
*Purpose: For obese patients with congestive heart failure (CHF), aggressive weight loss has been associated with ventricular remodeling. Many have suggested offering bariatric surgery for…
2022 American Transplant Congress
A Intention-to-Treat Analysis of 881 Consecutively Waitlisted Patients to Develop a Survival Benefit Model for Hepatocellular Carcinoma Liver Transplant Candidates
B. V. Tran¹, W. Lapisatepun¹, W. Dumronggittigule¹, D. Markovic², Y. Lee¹, F. Kaldas¹, D. Farmer¹, R. Busuttil¹, V. Agopian¹
¹Department of Surgery, University of California Los Angeles, Los Angeles, CA, ²Department of Medicine, Statistics Core, University of California Los Angeles, Los Angeles, CA
*Purpose: The current liver transplantation (LT) selection paradigm for hepatocellular carcinoma (HCC) patients ignores the variable risks of waitlist dropout and post-LT recurrence/death, with the…
2022 American Transplant Congress
The Correlation of Dd-cfdna and Donor Specific Antibodies in Kidney Transplant Recipients
S. Kant, T. Ishaque, A. Massie, D. C. Brennan, M. Bettinotti
Johns Hopkins Hospital, Baltimore, MD
*Purpose: Donor derived cell free DNA (dd-cfDNA) is increasingly being utilized to discern the presence of rejection in kidney transplant recipients (KTRs). There continues to…
2022 American Transplant Congress
Type 1 Innate Lymphoid Cells Alleviate Acute Liver Injury Following Transplantation via Interferon-γ Mediated Pathway
H. Kojima, K. Kadono, H. Hirao, K. J. Dery, J. Kupiec-Weglinski, Y. Zhai
Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: Innate lymphoid cells (ILCs), a heterogeneous population of non-B non-T lymphocytes, have been found in recent years to plays key regulatory roles in tissue…
2022 American Transplant Congress
Association of Change in Kidney Volume with Proteinuria After Donation
M. Tsujita¹, K. Uchida¹, K. Morozumi¹, K. Futamura², T. Hiramitsu², M. Okada², S. Narumi², N. Goto², Y. Watarai²
¹Masuko Memorial Hospital, Nagoya, Japan, ²Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan
*Purpose: In living kidney transplantation, the risk of end-stage kidney disease in kidney donors is crucial, however, it still remains to be resolved. Any useful…